查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1708409

非侵入性血糖监测设备市场：按技术、按方式、按最终用户、按地区。

Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, By Modality, By End User, By Geography .
出版日期: | 出版商: Coherent Market Insights | 英文 163 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球非侵入式血糖监测设备市场规模估计为 2,430 万美元，预计到 2032 年将达到 6,830 万美元，2025 年至 2032 年的复合年增长率为 15.9%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 2430万美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 15.90% 2032年价值预测 6830万美元
数字。 2025年非侵入性血糖监测设备市场占有率（按地区）
非侵入性血糖监测设备市场-IMG1

非侵入性血糖监测，顾名思义就是在不对人体组织造成损伤的情况下进行血糖检测。与传统的指尖采血方法相比，非侵入性血糖监测设备提供了一种经济且无痛的血糖值监测方法。这些设备的工作原理是扫描皮肤附近的血管而不是抽血。微创微针、近红外线光谱、超宽频雷达等血糖检测技术的发展，促进了能够忠实反映侵入式监测方法测量结果的非侵入式产品的开发。这为糖尿病患者提供了更大的便利，并提高了他们管理病情的依从性。非侵入式血糖监测设备可依技术分为电磁波、经皮、光学和酵素。

市场动态：

非侵入性血糖监测设备市场受到全球糖尿病盛行率上升和持续血糖监测技术进步的推动。许多新参与企业带着新颖的解决方案进入市场，帮助克服指尖采血等现有侵入性技术的挑战。然而，与参考方法相比，实现高精度的技术限制、临床检验不足以及监管部门核准延迟等因素继续限制其广泛应用。也就是说，正在进行的专注于改进演算法和感测器的研究和开发为非侵入性解决方案成为传统血糖测试的可行替代方案提供了良好的机会。

预计缺乏知识和诊断将在预测期内阻碍全球非侵入性血糖监测设备市场的成长。

本研究的主要特点

  • 本报告对全球非侵入式血糖监测设备市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
  • 它揭示了各个领域的潜在收益成长机会，并解释了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数，介绍了全球无创血糖监测设备市场的主要企业概况。
  • 本研究报告中介绍的主要企业包括 Baxter International Inc.、Dexcom, Inc.、Abbott、Medtronic、Senseonics Holdings, Inc.、GlySens Incorporated、DiaMonTech GmbH、Nemaura Medical Inc.、Integrity Applications, Inc.、CNOGA Medical Ltd.、Breath Health, Inc. A/S。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球非侵入性血糖监测设备市场的各种策略矩阵来更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 需要使用新斯的明治疗的疾病（如重症肌无力和术后肠阻塞）的发生率正在增加。
    • 限制因素
  • 缺乏知识和诊断
    • 机会
  • 兽医学发展
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球非侵入性血糖监测设备市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球非侵入性血糖监测设备市场（依技术划分），2020 年至 2032 年

  • 电磁波
  • 经皮
  • 光学
  • 酵素

6. 全球非侵入性血糖监测设备市场（依模式划分），2020 年至 2032 年

  • 穿戴式装置
  • 非穿戴式/桌上型
  • 嵌入式装置

7. 全球非侵入性血糖监测设备市场（依最终用户划分），2020 年至 2032 年

  • 医院
  • 诊所
  • 居家照护环境

8. 全球非侵入性血糖监测设备市场（按地区），2020 年至 2032 年

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲

第九章 竞争态势

  • Baxter International Inc.
  • Dexcom, Inc
  • Abbott
  • Medtronic
  • Senseonics Holdings, Inc
  • GlySens Incorporated
  • DiaMonTech GmbH
  • Nemaura Medical Inc.
  • Integrity Applications, Inc.
  • CNOGA Medical Ltd
  • Breath Health, Inc.
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1480

Global Non-Invasive Blood Glucose Monitoring Devices Market is estimated to be valued at USD 24.3 Mn in 2025 and is expected to reach USD 68.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 15.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 24.3 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.90% 2032 Value Projection: USD 68.3 Mn
Figure. Non-Invasive Blood Glucose Monitoring Devices Market Share (%), By Region 2025
Non-Invasive Blood Glucose Monitoring Devices Market - IMG1

Non-invasive blood glucose monitoring, as its name implies, refers to the detection of human blood glucose without causing damage to human tissues. Non-invasive blood glucose monitoring devices offer an economical and pain-free method to monitor blood glucose levels compared to traditional finger-pricking methods. These devices work by scanning the blood vessels near the skin instead of drawing blood. Advancement in glucose sensing technologies, such as minimally-invasive micro needles, near infrared spectroscopy, and ultra wideband radar, have facilitated the development of non-invasive products that can closely mirror readings from invasive monitoring methods. This provides diabetics with greater convenience and compliance in managing their condition. Non-invasive blood glucose monitoring devices can be segmented on the basis of technology into EM waves, transdermal, optical, and enzymatic.

Market Dynamics:

The non-invasive blood glucose monitoring devices market is driven by the growing prevalence of diabetes worldwide as well as advancements in continuous glucose monitoring technologies. Many new players are entering the market with novel solutions that can help overcome the challenges with existing invasive methods like finger pricks. However, factors such as technical limitations in achieving high accuracy compared to reference methods, insufficient clinical validation, and slow regulatory approvals continue to restrain widespread adoption. Nonetheless, continued R&D focusing on improved algorithms and sensors offers promising opportunities for non-invasive solutions to become a viable alternative to conventional glucose tests.

Lack of knowledge and diagnosis are expected to hamper the growth of the global non-invasive blood glucose monitoring devices market over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global non-invasive blood glucose monitoring devices market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global non-invasive blood glucose monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • The key companies covered as a part of this study include Baxter International Inc., Dexcom, Inc, Abbott, Medtronic, Senseonics Holdings, Inc, GlySens Incorporated, DiaMonTech GmbH, Nemaura Medical Inc., Integrity Applications, Inc., CNOGA Medical Ltd., Breath Health, Inc., Metamaterial Technologies Inc., Opticology Inc., NovioSense BV, Quick LLC, and RSP Systems A/S.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global non-invasive blood glucose monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global non-invasive blood glucose monitoring devices market

Detailed Segmentation:

  • Global non-invasive blood glucose monitoring devices Market, By Technology:
    • EM Waves
    • Transdermal
    • Optical
    • Enzymatic
  • Global non-invasive blood glucose monitoring devices Market, By Modality:
    • Wearable
    • Non-wearable/Benchtop
    • Embedded Devices
  • Global non-invasive blood glucose monitoring devices Market, By End User:
    • Hospitals
    • Clinics
    • Homecare setting
  • Global non-invasive blood glucose monitoring devices Market, By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Baxter International Inc.
    • Dexcom, Inc
    • Abbott
    • Medtronic
    • Senseonics Holdings, Inc
    • GlySens Incorporated
    • DiaMonTech GmbH
    • Nemaura Medical Inc.
    • Integrity Applications, Inc.
    • CNOGA Medical Ltd.
    • Breath Health, Inc.
    • Metamaterial Technologies Inc.
    • Opticology Inc.
    • NovioSense BV
    • Quick LLC
    • RSP Systems A/S.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Modality
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Rising prevalence of diseases like myasthenia gravis and postoperative ileus requiring neostigmine
    • Restraints
  • Lack of knowledge and diagnosis
    • Opportunities
  • The growth of veterinary medicine
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Non-Invasive Blood Glucose Monitoring Devices Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Technology, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • EM Waves
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Transdermal
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Optical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Enzymatic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Modality, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Wearable
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Non-wearable/Benchtop
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Embedded Devices
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Non-Invasive Blood Glucose Monitoring Devices Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Homecare setting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Non-Invasive Blood Glucose Monitoring Devices Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub Region, 2020-2032,(US$ Mn)
      • GCC
      • Israel
      • Rest of Middle East
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dexcom, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Senseonics Holdings, Inc
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlySens Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaMonTech GmbH
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nemaura Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Integrity Applications, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • CNOGA Medical Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Breath Health, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Metamaterial Technologies Inc.
  • Opticology Inc.
  • NovioSense BV
  • Quick LLC
  • RSP Systems A/S.
  • Analyst Views

10. Section

  • Research Methodology
  • About us